TGFB1 and central nervous system cancer: Knocking out HM13 significantly inhibits tumor cell survival, reduces cytokine secretion in EGFRvIII glioma cells, and affects the biological behavior of surrounding cells by mediating the TGF-β pathway (Delman, 2020).